Phytoalexins: Sources and Their Pharmacological Potential

dc.contributor.authorRakesh K Sindhu
dc.contributor.authorBhavika Arora
dc.contributor.authorSandeep Arora
dc.date.accessioned2025-12-18T08:48:49Z
dc.date.available2025-12-18T08:48:49Z
dc.date.issued2020-05-20
dc.description.abstractBackground: Plants are easily prone towards microbial infections on exposure to microorganisms and pathogens. In order to defense, plants produce low molecular weight secondary metabolites which were later known as “Phytoalexins”. These molecules have vast therapeutic potential also. Purpose: The purpose of this review is to explore the phytoalexins and their pharmacological effects. Methods: The data included from the articles were published from Web of Science, PubMed, Medline, Scopus, and Embase by using relevant keywords including plants possessing phytoalexins and their specific biological applications. Results: The review insights the potential of phytoalexins in various diseases and to explore phytoalexins applications in human health and disease control. Conclusions: On the basis of this review it may be concluded that phytoalexins have tremendous potential in the treatment and prevention of various life-threatening diseases like diabetes mellitus, cancer, brain damage, and heart attack.
dc.identifier.issn2321-2217
dc.identifier.issn2321-2225
dc.identifier.otherhttps://doi.org/10.15415/jptrm.2020.81001
dc.identifier.urihttps://demodspace.chitkara.edu.in/handle/123456789/237
dc.language.isoen
dc.publisherChitkara University Publications
dc.subjectPhytoalexins
dc.subjectResveratrol
dc.subjectAnti-Diabetic
dc.subjectAnti-Cancer
dc.subjectCardio-Protective
dc.subjectNeuro-Protective
dc.titlePhytoalexins: Sources and Their Pharmacological Potential
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JPTRM Volume 8 Issue 1 001.pdf
Size:
353.07 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: